CLOFEZONE ANHYDROUS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H20N2O2.C14H21ClN2O2
Molecular Weight	593.156
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCN(CC)CCNC(=O)COC1=CC=C(Cl)C=C1.CCCCC2C(=O)N(N(C2=O)C3=CC=CC=C3)C4=CC=CC=C4

InChI

InChIKey=ICBCZMIEENEERJ-UHFFFAOYSA-N

InChI=1S/C19H20N2O2.C14H21ClN2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16;1-3-17(4-2)10-9-16-14(18)11-19-13-7-5-12(15)6-8-13/h4-13,17H,2-3,14H2,1H3;5-8H,3-4,9-11H2,1-2H3,(H,16,18)

HIDE SMILES / InChI

Molecular Formula	C14H21ClN2O2
Molecular Weight	284.782
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C19H20N2O2
Molecular Weight	308.3743
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/153679 | https://www.ncbi.nlm.nih.gov/pubmed/5555631 | https://www.ncbi.nlm.nih.gov/pubmed/4927184 | https://www.ncbi.nlm.nih.gov/pubmed/132816

Clofezone (Perclusone), an analgesic and anti-inflammatory agent, is a drug that was used to treat joint and muscular pain, mostly in rheumatic diseases. Clofezone is a compound preparation of phenylbutazone and clofexamide. Tolerance of Perclusone was very good, no side-effects were observed.

Originator

Approval Year

PubMed

Title	Date	PubMed
[Clinical trial of a new anti-inflammatory agent in rheumatology, ANP 3260 or clofezone].	1968 Mar	4927184
[Long-term therapy of rheumatoid arthritis with perclusone].	1975 May-Jun	132816
Comparison of clofezone and diclofenac in the treatment of out-patients suffering from activated (painful) osteoarthrosis.	1978 Sep-Oct	153679

Patents

Sample Use Guides

In Vivo Use Guide

The effectiveness and acceptability of clofezone (Perclusone) were compared with those of diclofenac in a placebo-controlled, double-blind, cross-over trial on a group of 29 out-patients suffering from osteoarthrosis of the knee or hip. Clofezone was given at a daily dosage of 1200 mg during the first week and 600 mg during the second week; the corresponding dosages of diclofenac were 150 mg and 75 mg.

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Fri Dec 15 18:45:01 GMT 2023` Edited by `admin` on `Fri Dec 15 18:45:01 GMT 2023`
Record UNII	5RB28NE79Y
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CLOFEZONE ANHYDROUS

Common Name

English

3,5-PYRAZOLIDINEDIONE, 4-BUTYL-1,2-DIPHENYL-, COMPD. WITH 2-(4-CHLOROPHENOXY)-N-(2-(DIETHYLAMINO)ETHYL)ACETAMIDE (1:1)

Systematic Name

English

ACETAMIDE, 2-(4-CHLOROPHENOXY)-N-(2-(DIETHYLAMINO)ETHYL)-, COMPD. WITH 4-BUTYL-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE (1:1)

Systematic Name

English

CLOFEXAMIDE-PHENYLBUTAZONE

Common Name

English

Classification Tree Code System Code

WHO-ATC

M01AA05